Paul Bertone
Auto-generated profile, based on publicly available information

Paul Bertone

Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2001 in Science
Verified
Journal Article
Closed access
PDF file
HZHeng Zhu
Heng Zhu
MBMetin Bilgin
Metin Bilgin
RBRhonda Bangham
Rhonda Bangham
DHDavid Hall
David Hall
Antonio CasamayorAntonio Casamayor
Antonio Casamayor
MSMichael Snyder
Michael Snyder
To facilitate studies of the yeast proteome, we cloned 5800 open reading frames and overexpressed and purified their corresponding proteins. The proteins were printed onto slides at high spatial density to form a yeast proteome microarray and screened for their ability to interact with proteins and phospholipids. We identified many new calmodulin- and phospholipid-interacting proteins; a common potential binding motif was identified for many of the calmodulin-binding proteins. Thus, microarrays of an entire eukaryotic proteome can be prepared and screened for diverse biochemical activities. The microarrays can also be used to screen protein-drug interactions and to detect posttranslational modifications.

23 January 2013 in Nature
Verified
Journal Article
Closed access
PDF file
NGNick Goldman
Nick Goldman
PBPaul Bertone
Paul Bertone
SCSiyuan Chen
Siyuan Chen
CDChristophe Dessimoz
Christophe Dessimoz
ELEmily M. LeProust
Emily M. LeProust
EBEwan Birney
Ewan Birney

1 September 2014 in Cell
Verified
Journal Article
Open access
YTYasuhiro Takashima
Yasuhiro Takashima
GGGe Guo
Ge Guo
RLRemco Loos
Remco Loos
JNJennifer Nichols
Jennifer Nichols
GFGabriella Ficz
Gabriella Ficz
ASAustin Smith
Austin Smith
Current human pluripotent stem cells lack the transcription factor circuitry that governs the ground state of mouse embryonic stem cells (ESC). Here, we report that short-term expression of two components, NANOG and KLF2, is sufficient to ignite other elements of the network and reset the human pluripotent state. Inhibition of ERK and protein kinase C sustains a transgene-independent rewired state. Reset cells self-renew continuously without ERK signaling, are phenotypically stable, and are karyotypically intact. They differentiate in vitro and form teratomas in vivo. Metabolism is reprogrammed with activation of mitochondrial respiration as in ESC. DNA methylation is dramatically reduced and transcriptome state is globally realigned across multiple cell lines. Depletion of ground-state transcription factors, TFCP2L1 or KLF4, has marginal impact on conventional human pluripotent stem cells but collapses the reset state. These findings demonstrate feasibility of installing and propagating functional control circuitry for ground-state pluripotency in human cells.

24 December 2004 in Science
Verified
Journal Article
Closed access
PDF file
PBPaul Bertone
Paul Bertone
VSViktor Stolc
Viktor Stolc
TRThomas E. Royce
Thomas E. Royce
JRJoel S. Rozowsky
Joel S. Rozowsky
AUAlexander E. Urban
Alexander E. Urban
MSMichael Snyder
Michael Snyder
Elucidating the transcribed regions of the genome constitutes a fundamental aspect of human biology, yet this remains an outstanding problem. To comprehensively identify coding sequences, we constructed a series of high-density oligonucleotide tiling arrays representing sense and antisense strands of the entire nonrepetitive sequence of the human genome. Transcribed sequences were located across the genome via hybridization to complementary DNA samples, reverse-transcribed from polyadenylated RNA obtained from human liver tissue. In addition to identifying many known and predicted genes, we found 10,595 transcribed sequences not detected by other methods. A large fraction of these are located in intergenic regions distal from previously annotated genes and exhibit significant homology to other mammalian proteins.

3 November 2013 in Nature Methods
Verified
Journal Article
Open access
PDF file
TCThe RGASP Consortium
The RGASP Consortium
TSTamara Steijger
Tamara Steijger
JAJosep F. Abril
Josep F. Abril
PEPär G Engström
Pär G Engström
FKFelix Kokocinski
Felix Kokocinski
PBPaul Bertone
Paul Bertone
The RGASP consortium compared 25 RNA-seq analysis programs in their ability to identify exons, reconstruct transcripts and quantify expression levels. Assembly of isoforms and their expression levels in higher eukaryotes remains a challenge. We evaluated 25 protocol variants of 14 independent computational methods for exon identification, transcript reconstruction and expression-level quantification from RNA-seq data. Our results show that most algorithms are able to identify discrete transcript components with high success rates but that assembly of complete isoform structures poses a major challenge even when all constituent elements are identified. Expression-level estimates also varied widely across methods, even when based on similar transcript models. Consequently, the complexity of higher eukaryotic genomes imposes severe limitations on transcript recall and splice product discrimination that are likely to remain limiting factors for the analysis of current-generation RNA-seq data.

1 November 2000 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HZHeng Zhu
Heng Zhu
JKJames F. Klemic
James F. Klemic
SCSwan Chang
Swan Chang
PBPaul Bertone
Paul Bertone
Antonio CasamayorAntonio Casamayor
Antonio Casamayor
MSMichael Snyder
Michael Snyder